PFE Pfizer already picked up Metsera and now pledging $70 B investements in the US, I assume that includes acquisitions. Anyone having thoughts on whether Pfizer will pick up more smaller players like Viking? Is it reasonable to believe that Metsera will be the only leg they have if they truly want a piece of the obesity market?
PFE Will no longer be able to rip off the taxpayers who fund the research for their products. This will mean no more ripping people off, and fewer ill gained profits for pharma.